The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α Pathway
Open accessAbstract
Regulation of hepatic carbohydrate homeostasis is crucial for maintaining energy balance in the face of fluctuating nutrient availability. Here, we show that the hormone fibroblast growth factor 15/19 (FGF15/19), which is released postprandially from the small intestine, inhibits hepatic gluconeogenesis, like insulin. However, unlike insulin, which peaks in serum 15 min after feeding, FGF15/19 expression peaks approximately 45 min later, when bile acid concentrations increase in the small intestine. FGF15/19 blocks the expression of genes involved in gluconeogenesis through a mechanism involving the dephosphorylation and inactivation of the transcription factor cAMP regulatory element-binding protein (CREB). This in turn blunts expression of peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and other genes involved in hepatic metabolism. Overexpression of PGC-1α blocks the inhibitory effect of FGF15/19 on gluconeogenic gene expression. These results demonstrate that FGF15/19 works subsequent to insulin as a postprandial regulator of hepatic carbohydrate homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is recognized that intestine‐secreted FGF15 also plays a pivotal role in the regulation of energy metabolism and liver cell regeneration (Potthoff et al., 2011).”
From Akkermansia muciniphila alleviates high‐fat‐diet ‐related metabolic‐associated fatty liver disease by modulating gut microbiota and bile acids (2023) · cites this paper as Potthoff et al., 2011
Experimental — accuracy not yet measuredIn the citing paper
“FGF19 also increases liver protein and glycogen synthesis while repressing hepatic glucose production 43, 44, in order to ensure proper postprandial energy storage independently from insulin.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Transcriptional regulation by the phosphorylation-dependent factor CREB
Mayr, B., & Montminy, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085068 · Cited by 2,587
Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133
Gonzalez, G. A., & Montminy, M. (1989) · Cell · doi:10.1016/0092-8674(89)90013-5 · Cited by 2,464
Puigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076
Phosphorylated CREB binds specifically to the nuclear protein CBP
Chrivia, J. C., Kwok, R. P. S., Lamb, N., Hagiwara, M., Montminy, M. R., & Goodman, R. H. (1993) · Nature · doi:10.1038/365855a0 · Cited by 2,052
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Self-citationInagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Self-citationPGC-1 coactivators: inducible regulators of energy metabolism in health and disease
Finck, B. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27794 · Cited by 1,461
Self-citationNuclear protein CBP is a coactivator for the transcription factor CREB
Kwok, R. P. S., Lundblad, J. R., Chrivia, J. C., Richards, J. P., Bächinger, H. P., Brennan, R. G., Roberts, S. G. E., Green, M. R., & Goodman, R. H. (1994) · Nature · doi:10.1038/370223a0 · Cited by 1,443
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–428 of 428
Liver Steatosis: From Lipotoxicity to Cellular Damage
Puengel, T., & Tacke, F. (2024) · Springer eBooks · doi:10.1007/978-981-97-9519-2_4 · Cited by 2
The Correlation between NAFLD and T2DM
雷, 笑. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.152338
The Investigation into Correlation between Type 2 Diabetes Mellitus and the Gut Microbiota
Liu, S., & Zhu, A. M. (2025) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2025.1511022
Liu, X., He, X., Tian, H., Zhang, W., Chen, W., Xie, A., Ouyang, W., Wen, X., Chen, G., & Wu, K. (2025) · Water Biology and Security · doi:10.1016/j.watbs.2025.100531
Zhang, L. H., Zhou, Y., Wang, M., Li, Z., & Li, C. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.108102
Kan, S., Pi, C., Zhang, L., Guo, D., Niu, Z., Liu, Y., Duan, M., Pu, X., Bai, M., Zhou, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22624717
Zhong, Y., Xiao, Y., Gao, J., Zheng, Z., Zhang, Z., Yao, L., & Li, D. (2022) · Figshare · doi:10.6084/m9.figshare.21524261
Guo, S., Xi, Y., Qi, J., Yang, Z., Han, X., Ling, W., Bai, L., Huang, A., Hu, S., Hu, J., et al. (2026) · Poultry Science · doi:10.1016/j.psj.2026.106525
Legume intake on gut microbiome and glycemia in type 2 diabetes management: narrative review
Hossain, M. A., Agyei, D., Reynolds, A. N., & Kebede, B. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1785186 · Cited by 2
Flodin, J., Amiri, P., Reitzner, S. M., Ahmed, A. S., & Ackermann, P. W. (2026) · European Journal of Applied Physiology · doi:10.1007/s00421-026-06216-7
Coopération oncogénique et effets métaboliques de FGF19 dans le carcinome hépatocellulaire
Bedoya, J. U. (2021) · theses.fr (ABES) · doi:10.70675/d2df913bz04e7z457dzb21dzf6ae23303e0c
Influence of bile acids metabolism on hepatic immunity in mice
Guinot, V. (2022) · theses.fr (ABES) · doi:10.70675/b69bb11eza30fz4874z9af2za6e31b2d5ad8
HMMS in clinical therapy and precision medicine
Duan, L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-31402-5.00004-9
Wang, X., Jiang, Y., Feng, L., Luo, Y., Zhang, J., Wang, X., Wang, Y., Ma, Y., Hua, M., Jin, L., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158730
Dąbrowska, A. M., Chwil, M., & Urbańska, E. M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15083081
Non-Invasive Biomarkers for Assessing Liver Fibrosis in Biliary Atresia: A Literature Review
Bența, G., Grama, A., Mititelu, A., Niculae, A.-Ş., & Pop, T. L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125295
Han, S., Shin, J., Kim, J. C., & Na, D. H. (2026) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-026-00815-4
Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases
Chui, Z. S. W., Xue, Y., Wu, X., & Xu, A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100150
Liu, H., Li, H., Zhai, Y., Zhang, F., Huang, J., Sun, J., Lyu, Y., & Huang, M. (2026) · Food Chemistry X · doi:10.1016/j.fochx.2026.104244
Hyodeoxycholic acid ameliorates tacrolimus-induced diabetes by modulating the FXR-FGF15 axis
Hu, N., Qian, M., Liu, Y., Jiang, Z., Xu, C., Zhang, W., & Jiang, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1865237
Wang, W., Tang, Y., Wan, Z., Zhang, Z., Zheng, Z., Liu, H., Shu, Q., & Li, S. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108444
Reichert, M., Strowitzki, M. J., Tuffs, C., Amati, A., Amin, D., Raj, S., Sprenger, T., Hecker, A., & Schneider, M. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2927-4771
Kotlyarov, S. N., Котлярова, А. А., Catanzaro, R., & Marotta, F. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198614
Gut microbiota shaping fatty liver disease progression
Wysokińska, M., Mysza, M., Uryga, A., & Kolodziejczyk, A. A. (2026) · Life Science Alliance · doi:10.26508/lsa.202603756
Yang, R., Zhang, S., Fu, Z., Yang, Y., Wang, Q., Zhou, Y., Li, J., Yang, R., Ning, S., Shi, Y., et al. (2026) · Medicinal Research Reviews · doi:10.1002/med.70117
Bai, L., Bai, D., Han, L., & Yang, Q. (2026) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2026.128
Metadata
- Authors
- Potthoff, M. J., Boney-Montoya, J., Choi, M., He, T., Sunny, N. E., Satapati, S., Suino-Powell, K., Xu, H. E., Gerard, R. D., Finck, B. N., Burgess, S. C., Mangelsdorf, D. J., & Kliewer, S. A.
- Affiliations
- Howard Hughes Medical Institute (US)
- The University of Texas Southwestern Medical Center (US)
- Van Andel Institute (US)
- Washington University in St. Louis (US)
- Corresponding author
- Mangelsdorf, David J.
- Kliewer, Steven A.
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 13
- Issue
- 6
- Pages
- 729-738
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC3131185
- OpenAlex
- W2020515276
- Cited by
- 431
- References
- 51
- Citations by year
- 2026: 24 · 2025: 28 · 2024: 34 · 2023: 28 · 2022: 47 · 2021: 39 · 2020: 30 · 2019: 25 · 2018: 22 · 2017: 34 · 2016: 18 · 2015: 28 · 2014: 22 · 2013: 20 · 2012: 24
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 777 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (DK067158, DK076269, DK078184, DK078187, U19DK62434)
- Howard Hughes Medical Institute
- Welch Foundation (I-1275, I-1588)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- FGF15/19, hepatic gluconeogenesis, CREB, PGC-1α, hepatic glucose metabolism, carbohydrate homeostasis, bile acids, insulin, transcriptional regulation, dephosphorylation
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Citric Acid Cycle, Fatty Acids, Fibroblast Growth Factors, Gluconeogenesis, Glucose, Liver, Luciferases, Male, Mice, Inbred C57BL, Oxidation-Reduction, Transcription Factors, Signal Transduction, Trans-Activators, Gene Expression, Cyclic AMP Response Element-Binding Protein, Genes, Reporter, Mice, Knockout, Gene Expression Profiling, Mice, Metabolic Networks and Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
